The Cannabinoid CB1 Receptor Antagonist Rimonabant Stimulates 2-Deoxyglucose Uptake in Skeletal Muscle Cells by Regulating the Expression of Phosphatidylinositol-3-kinase

2008 ◽  
Vol 74 (6) ◽  
pp. 1678-1686 ◽  
Author(s):  
Iolanda Esposito ◽  
Maria Chiara Proto ◽  
Patrizia Gazzerro ◽  
Chiara Laezza ◽  
Claudia Miele ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Receptor Antagonist ◽  
Muscle Cells ◽  
Cb1 Receptor ◽  
Skeletal Muscle Cells ◽  
Phosphatidylinositol 3 Kinase ◽  
Cannabinoid Cb1 Receptor ◽  
Cb1 Receptor Antagonist ◽  
Cannabinoid Cb1 Receptor Antagonist ◽  
Phosphatidylinositol 3

scholarly journals Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

2009 ◽  
Vol 29 (1) ◽  
pp. 12-18 ◽  
Author(s):  
Frédérique Dol-Gleizes ◽  
Réjane Paumelle ◽  
Virgile Visentin ◽  
Anne-Marie Marés ◽  
Perrine Desitter ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Ldl Receptor ◽  
Cb1 Receptor ◽  
Cannabinoid Cb1 Receptor ◽  
Cb1 Receptor Antagonist ◽  
Deficient Mice ◽  
Cannabinoid Cb1 Receptor Antagonist

scholarly journals Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

2008 ◽  
Vol 33 (12) ◽  
pp. 2870-2877 ◽  
Author(s):  
Zuzana Justinova ◽  
Patrik Munzar ◽  
Leigh V Panlilio ◽  
Sevil Yasar ◽  
Godfrey H Redhi ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Cb1 Receptor ◽  
Cannabinoid Cb1 Receptor ◽  
Seeking Behavior ◽  
Cb1 Receptor Antagonist ◽  
Cannabinoid Cb1 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document